106P Efficacy and safety of IBI351 (GFH925) monotherapy in metastatic colorectal cancer harboring KRASG12C mutation: Updated results from a pooled analysis of two phase I studiesYanggang Yuan, Kaiyang Ding, Mingyu Sun et al.|Annals of Oncology|2023Cited by 11